NO20054095D0 - Pyridyloksymetyl og benzioksazolazabicyklisk derivater - Google Patents

Pyridyloksymetyl og benzioksazolazabicyklisk derivater

Info

Publication number: NO20054095D0
Authority: NO; Norway
Prior art keywords: benzioxazolazabicyclic; pyridyloxymethyl; derivatives; benzioxazolazabicyclic derivatives
Prior art date: 2003-03-12

Application number

NO20054095A

Other languages

English (en)

Other versions

NO20054095L (no

Inventor

Gene Michael Bright

Bishop Wlodecki

Michael Aaron Brodney

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-12

Filing date

2005-09-02

Publication date

2005-09-02

2005-09-02 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2005-09-02 Publication of NO20054095D0 publication Critical patent/NO20054095D0/no

2005-09-26 Publication of NO20054095L publication Critical patent/NO20054095L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Pregnancy & Childbirth (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO20054095A 2003-03-12 2005-09-02 Pyridyloksymetyl og benzioksazolazabicyklisk derivater NO20054095L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45392503P	2003-03-12	2003-03-12
PCT/IB2004/000499 WO2004081007A1 (en)	2003-03-12	2004-02-23	Pyridyloxymethyl and benzisoxazole azabicyclic derivatives

Publications (2)

Publication Number	Publication Date
NO20054095D0 true NO20054095D0 (no)	2005-09-02
NO20054095L NO20054095L (no)	2005-09-26

Family

ID=32990837

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054095A NO20054095L (no)	2003-03-12	2005-09-02	Pyridyloksymetyl og benzioksazolazabicyklisk derivater

Country Status (30)

Country	Link
US (1)	US7345038B2 (no)
EP (1)	EP1608648B1 (no)
JP (2)	JP3910627B2 (no)
KR (2)	KR20070074667A (no)
CN (1)	CN100389115C (no)
AP (1)	AP2005003390A0 (no)
AR (1)	AR043537A1 (no)
AU (2)	AU2004220327B2 (no)
BR (1)	BRPI0408248A (no)
CA (1)	CA2518740C (no)
EA (1)	EA009527B1 (no)
EC (1)	ECSP056011A (no)
GT (1)	GT200400041A (no)
HR (1)	HRP20050798A2 (no)
IL (1)	IL170290A (no)
MA (1)	MA27747A1 (no)
MX (1)	MXPA05009660A (no)
NL (1)	NL1025710C2 (no)
NO (1)	NO20054095L (no)
OA (1)	OA13038A (no)
PA (1)	PA8597501A1 (no)
PE (1)	PE20041057A1 (no)
PL (1)	PL378749A1 (no)
RS (1)	RS20050692A (no)
TN (1)	TNSN05224A1 (no)
TW (1)	TW200502234A (no)
UA (1)	UA78437C2 (no)
UY (1)	UY28225A1 (no)
WO (1)	WO2004081007A1 (no)
ZA (1)	ZA200506373B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6994726B2 (en) *	2004-05-25	2006-02-07	Calcitec, Inc.	Dual function prosthetic bone implant and method for preparing the same
RU2405784C2 (ru)	2003-10-15	2010-12-10	Оси Фармасьютикалз, Инк.	Имидазопиразины в качестве ингибиторов тирозинкиназ
MXPA06008647A (es) *	2004-01-29	2006-09-04	Pfizer Prod Inc	Combinaciones de un antipsicotico atipico y derivados azabiciclicos aminometilpiridiloximetil/bencisoxazol para tratar trastornos del sistema nervioso central.
CN1960993A (zh)	2004-04-02	2007-05-09	Osi制药公司	6,6－双环取代的杂双环蛋白激酶抑制剂
AR053090A1 (es)	2004-07-20	2007-04-25	Osi Pharm Inc	Imidazotriazinas como inhibidores de proteina quinasas y su uso para la preparacion de medicamentos
BRPI0514793A (pt) *	2004-09-10	2008-06-24	Pfizer Prod Inc	uso de derivados azabicìclicos de benzisoxazol e piridiloximetila na preparação de um medicamento para o tratamento de distúrbios cognitivos
US8575164B2 (en) *	2005-12-19	2013-11-05	OSI Pharmaceuticals, LLC	Combination cancer therapy
WO2009091939A1 (en) *	2008-01-18	2009-07-23	Osi Pharmaceuticals, Inc.	Imidazopyrazinol derivatives for the treatment of cancers
WO2009143051A1 (en) *	2008-05-19	2009-11-26	Osi Pharmaceuticals, Inc.	Substituted imidazopyr-and imidazotri-azines
MX2011011025A (es)	2009-04-20	2011-11-02	Osi Pharmaceuticals Llc	Preparacion de c-piracin-metilaminas.
JP2012526138A (ja) *	2009-05-07	2012-10-25	オーエスアイ・ファーマシューティカルズ，エルエルシー	副腎皮質癌を治療するためのｏｓｉ−９０６の使用
JP2013540145A (ja) *	2010-10-21	2013-10-31	ウニベルシテートデスザールランデス	コルチゾール依存性疾患の治療用の選択的ｃｙｐ１１ｂ１阻害剤
HK1215170A1 (zh)	2012-11-14	2016-08-19	The Johns Hopkins University	治療精神分裂症的方法和組合物
WO2016115282A1 (en) *	2015-01-13	2016-07-21	Vanderbilt University	Benzoisoxazole-substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US9585867B2 (en)	2015-08-06	2017-03-07	Charles Everett Ankner	Cannabinod formulation for the sedation of a human or animal
WO2020183011A1 (en)	2019-03-14	2020-09-17	Institut Curie	Htr1d inhibitors and uses thereof in the treatment of cancer
EP4429465A1 (en)	2021-11-10	2024-09-18	Symrise AG	Compositions comprising trpm8 agonistic cooling agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990008148A1 (en)	1989-01-23	1990-07-26	Pfizer Inc.	Bis-aza-bicyclic anxiolytic agents
US5167034A (en) *	1990-06-18	1992-11-24	International Business Machines Corporation	Data integrity for compaction devices
US5157034A (en)	1991-02-27	1992-10-20	Pfizer Inc.	Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
HUT71488A (en)	1991-09-25	1995-11-28	Pfizer	Process for the production of neuroleptic 2-substituted perhydro-1-h-pyrido[1,2a]pyrazines and pharmaceuticals compositions containing the same
CA2138018C (en)	1992-06-16	1998-01-27	Frank J. Urban	Process and intermediates for bis-aza-bicyclic anxiolytic agents
WO1996010570A1 (en)	1994-09-30	1996-04-11	Pfizer Inc.	NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
SK284994B6 (sk)	1997-05-30	2006-04-06	Neurosearch A/S	Deriváty 8-azabicyklo[3.2.1]okt-2-énu, spôsob ich prípravy a ich použitie
PA8469101A1 (es) *	1998-04-09	2000-09-29	Pfizer Prod Inc	Ligandos azabiciclicos de receptores 5ht1
AU754557B2 (en)	1998-08-26	2002-11-21	Aventis Pharma Limited	Aza-bicycles which modulate the inhibition of cell adhesion
HUP0200355A3 (en)	1998-09-18	2004-07-28	Abbott Gmbh & Co Kg	4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use
HUP0200403A3 (en)	1998-09-18	2004-07-28	Abbott Gmbh & Co Kg	Pyrrolopyrimidines as protein kinase inhibitors, pharmaceutical compositions containing them and their use
UA62015C2 (en) *	1998-12-28	2003-12-15	Pfizer Prod Inc	Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
HK1043127B (zh)	1999-03-12	2004-12-24	贝林格尔‧英格海姆药物公司	作为消炎剂的化合物
EP1177792A3 (en) *	2000-07-27	2002-10-23	Pfizer Products Inc.	Dopamine D4 Ligands for the treatment of novelty-seeking disorders

2004
- 2004-02-23 EP EP04713592A patent/EP1608648B1/en not_active Expired - Lifetime
- 2004-02-23 AP AP2005003390A patent/AP2005003390A0/xx unknown
- 2004-02-23 OA OA1200500259A patent/OA13038A/en unknown
- 2004-02-23 KR KR1020077013527A patent/KR20070074667A/ko not_active Withdrawn
- 2004-02-23 JP JP2006506261A patent/JP3910627B2/ja not_active Expired - Fee Related
- 2004-02-23 HR HR20050798A patent/HRP20050798A2/hr not_active Application Discontinuation
- 2004-02-23 MX MXPA05009660A patent/MXPA05009660A/es active IP Right Grant
- 2004-02-23 EA EA200501148A patent/EA009527B1/ru not_active IP Right Cessation
- 2004-02-23 CN CNB2004800066516A patent/CN100389115C/zh not_active Expired - Fee Related
- 2004-02-23 KR KR1020057016859A patent/KR100767854B1/ko not_active Expired - Fee Related
- 2004-02-23 CA CA2518740A patent/CA2518740C/en not_active Expired - Fee Related
- 2004-02-23 UA UAA200508639A patent/UA78437C2/uk unknown
- 2004-02-23 RS YUP-2005/0692A patent/RS20050692A/sr unknown
- 2004-02-23 BR BRPI0408248-6A patent/BRPI0408248A/pt not_active IP Right Cessation
- 2004-02-23 AU AU2004220327A patent/AU2004220327B2/en not_active Ceased
- 2004-02-23 WO PCT/IB2004/000499 patent/WO2004081007A1/en not_active Ceased
- 2004-02-23 PL PL378749A patent/PL378749A1/pl not_active Application Discontinuation
- 2004-03-08 PA PA20048597501A patent/PA8597501A1/es unknown
- 2004-03-09 PE PE2004000256A patent/PE20041057A1/es not_active Application Discontinuation
- 2004-03-10 AR ARP040100770A patent/AR043537A1/es not_active Application Discontinuation
- 2004-03-11 TW TW093106481A patent/TW200502234A/zh unknown
- 2004-03-11 GT GT200400041A patent/GT200400041A/es unknown
- 2004-03-11 UY UY28225A patent/UY28225A1/es not_active Application Discontinuation
- 2004-03-12 NL NL1025710A patent/NL1025710C2/nl not_active IP Right Cessation
- 2004-03-12 US US10/800,328 patent/US7345038B2/en not_active Expired - Fee Related
2005
- 2005-08-10 ZA ZA200506373A patent/ZA200506373B/en unknown
- 2005-08-15 IL IL170290A patent/IL170290A/en not_active IP Right Cessation
- 2005-09-02 NO NO20054095A patent/NO20054095L/no unknown
- 2005-09-12 EC EC2005006011A patent/ECSP056011A/es unknown
- 2005-09-12 MA MA28495A patent/MA27747A1/fr unknown
- 2005-09-12 TN TNP2005000224A patent/TNSN05224A1/fr unknown
2006
- 2006-10-26 JP JP2006291545A patent/JP2007051155A/ja active Pending
2010
- 2010-07-23 AU AU2010203303A patent/AU2010203303A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2007051155A (ja)	2007-03-01
BRPI0408248A (pt)	2006-03-01
AU2010203303A1 (en)	2010-08-12
US20050026922A1 (en)	2005-02-03
PA8597501A1 (es)	2005-05-24
TW200502234A (en)	2005-01-16
MA27747A1 (fr)	2006-02-01
AU2004220327A1 (en)	2004-09-23
CN1759116A (zh)	2006-04-12
NL1025710C2 (nl)	2005-10-10
AR043537A1 (es)	2005-08-03
UA78437C2 (en)	2007-03-15
PL378749A1 (pl)	2006-05-15
CN100389115C (zh)	2008-05-21
OA13038A (en)	2006-11-10
CA2518740C (en)	2011-01-11
NL1025710A1 (nl)	2004-09-14
JP2006519830A (ja)	2006-08-31
AP2005003390A0 (en)	2005-09-30
EP1608648A1 (en)	2005-12-28
EA009527B1 (ru)	2008-02-28
US7345038B2 (en)	2008-03-18
HRP20050798A2 (en)	2006-02-28
IL170290A (en)	2011-02-28
ZA200506373B (en)	2006-10-25
UY28225A1 (es)	2004-11-08
KR100767854B1 (ko)	2007-10-17
AU2004220327B2 (en)	2010-06-24
JP3910627B2 (ja)	2007-04-25
GT200400041A (es)	2005-03-23
RS20050692A (sr)	2007-11-15
WO2004081007A1 (en)	2004-09-23
KR20070074667A (ko)	2007-07-12
NO20054095L (no)	2005-09-26
EA200501148A1 (ru)	2006-04-28
PE20041057A1 (es)	2005-01-22
TNSN05224A1 (fr)	2007-06-11
KR20050113221A (ko)	2005-12-01
HK1085725A1 (zh)	2006-09-01
ECSP056011A (es)	2006-01-27
EP1608648B1 (en)	2012-07-18
CA2518740A1 (en)	2004-09-23
MXPA05009660A (es)	2005-10-20

Publication	Publication Date	Title
IS8153A (is)	2005-11-28	Ónæmisbælandi efnasambönd og efnablöndur
ATE340782T1 (de)	2006-10-15	Piperidinbenzolsulfonamidderivate
NO20032220D0 (no)	2003-05-15	Löfteverktöy II og fremgangsmåte for anvendelse av samme
IS2504B (is)	2009-04-15	Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
IS8146A (is)	2005-11-24	Setnar 3-alkýl og 3-alkenýl asetidín afleiður
ATE478870T1 (de)	2010-09-15	Spiroindolinpiperidinderivate
ATE460418T1 (de)	2010-03-15	Heterocyclocarboxamidderivate
ATE450506T1 (de)	2009-12-15	Indol-3-schwefelderivate
ATE467631T1 (de)	2010-05-15	Chinuclidinamidderivate
DK1474408T3 (da)	2012-06-25	N-Phenyl-2-pyrimidinaminderivater
ATE352550T1 (de)	2007-02-15	Chinazolinderivate
DK1682493T3 (da)	2009-04-20	Amidoacetonitrilderivater
ATE395345T1 (de)	2008-05-15	Imidazol-4-yl-ethynyl-pyridin-derivate
DK1675852T3 (da)	2009-05-25	Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
IS8529A (is)	2006-07-14	Rífamísínhliðstæður og notkun þeirra
ATE512148T1 (de)	2011-06-15	Pyrazolo- und imidazopyrimidinderivate
NO20054095D0 (no)	2005-09-02	Pyridyloksymetyl og benzioksazolazabicyklisk derivater
DK1562918T3 (da)	2008-05-05	Substituerede benzoxazinoner og anvendelser deraf
DK1601744T3 (da)	2012-08-20	Forgasningsapparat og fremgangsmåde
NO20054135D0 (no)	2005-09-06	Kipolinon/benzoksazin derivater og anvendelser derav
DE60307512D1 (de)	2006-09-21	3h-chinazoline -4-on derivaten
ATE354365T1 (de)	2007-03-15	N-thiazol-2-yl-benzamid-derivate
ATE423771T1 (de)	2009-03-15	Tetrahydrochinolinderivate
DK1706373T3 (da)	2010-01-18	Amidoacetonitrilderivater
IS8045A (is)	2005-09-26	Púrín-6-ón-afleiður